Tumorigenesis requires interactions between tumor progenitors and their microenvironment. We found that low cAMP levels were sufficient for tumorigenesis in a mouse model of Neurofibromatosis-1 (NF1)-associated optic pathway glioma (OPG). We hypothesized that the distinct pattern of glioma in NF1 reflected spatiotemporal differences in CXCL12 effects on cAMP levels. Thus, we sought to alter the pattern of gliomagenesis through manipulation of CXCL12-CXCR4 pathway activation in Nf1 OPG mice. Forced CXCL12 expression induced glioma at a low frequency. Further, treatment of Nf1 OPG mice with AMD3100, a CXCR4 antagonist, did not attenuate glioma growth. Thus, it appears, CXCL12 alone cannot promote gliomagenesis in NF1 mice.
Introduction
Recent studies demonstrate a critical role for the microenvironment in tumor initiation and promotion (Polyak et al., 2009) , and show that acquisition of genetic alterations within tumor progenitors is necessary, but often not sufficient, for tumor formation. Microenvironmental prerequisites for tumorigenesis are well illustrated by brain tumor (glioma) formation in Neurofibromatosis-1 (NF1) (Rubin and Gutmann, 2005) . NF1 is an autosomal dominant tumor predisposition syndrome associated with benign and malignant neoplasms of both the peripheral and central nervous systems (Williams et al., 2009) . Approximately 15-20% of NF1 patients develop low-grade astrocytomas with homozygous inactivation of the neurofibromin (NF1) gene in the neoplastic cells (Gutmann et al., 2000; Kluwe et al., 2001; Listernick et al., 1997) . While loss of the second NF1 allele is likely to be a random event, NF1-associated gliomas predominantly occur in optic nerve and chiasm of young children (Listernick et al., 2007) . This unique pattern of tumorigenesis, referred to as optic pathway glioma (OPG), suggests the existence of a secondary mechanism that specifies the timing and location of tumor formation.
NF1 is a tumor suppressor gene encoding neurofibromin, a GTPaseactivating protein and negative regulator of p21-RAS activity (Ballester et al., 1990; Martin et al., 1990; Phillips et al., 2003) . Loss of neurofibromin results in elevated p21-RAS signaling and confers a hyperproliferative phenotype in Nf1 −/− cells (DeClue et al., 1992; Feldkamp et al., 1999) . In addition, neurofibromin positively regulates cAMP generation in astrocytes and neurons (Dasgupta et al., 2003; Hegedus et al., 2007; Tong et al., 2002) . Surprisingly, despite the increased proliferation associated with neurofibromin loss, complete loss of Nf1 function in murine astrocytes is not sufficient for gliomagenesis (Bajenaru et al., 2002) : NF1-associated OPG development also requires heterozygous Nf1 loss (Nf1 +/− ) in the tumor microenvironment (Bajenaru et al., 2003; Zhu et al., 2005) . Previously, we showed that CXCL12 exhibits a spatial/temporal pattern of expression during brain development that correlates with OPG formation in NF1 (Warrington et al., 2007) . CXCL12 is a chemokine that functions through its receptor CXCR4 to regulate multiple cellular responses, including activation of PI3K/AKT, MAPK pathways and decreases of intracellular cyclic AMP (cAMP) levels (reviewed in (Rubin, 2009) ). Differences in CXCL12-induced cAMP levels were found to stimulate increased survival of Nf1−/−, compared to wildtype, astrocytes in vitro (Warrington et al., 2007) . These findings suggested that low levels of cAMP, together with complete glial (astrocyte) Nf1 inactivation might confer susceptible hyperproliferating Nf1 −/− progenitors with an additional growth advantage sufficient to facilitate oncogenic transformation.
To confirm the importance of cAMP in glioma formation, cAMPspecific phosphodiesterase-4A1 (PDE4A1) was ectopically expressed in the cortex of Nf1 OPG mice. PDE4A1 overexpression resulted in foci Journal of Neuroimmunology 224 (2010) 108-113 
